Merck KGaA, Darmstadt, Germany and Artios Pharma Announce a Global Strategic Collaboration on Novel DNA Damage Response Targets in Oncology
| Press release
News & Events
We are excited to announce Artios has moved to brand new labs and offices on the Babraham Research Campus.
| Announcement
Artios attending 38th Annual J.P Morgan Healthcare Conference in San Francisco, January 12-16 2020
| Announcement
Artios Pharma, MD Anderson and ShangPharma announce in-licensing agreement for DNA damage response inhibitor
| Press release
Artios Pharma appoints Tania Dimitrova as Chief Business Officer and expands presence in the United States
| Press release
Biotech CEO’s: Can Scientist Founders Remain in Charge?
| Media coverage
‘Putting DNA repair on the map’- Artios CEO interviewed by Labiotech
| Media coverage
